Is it safe to continue biologic agents during surgery in patients with inflammatory bowel disease?

Address: Zain Moosvi, MD, Department of Internal Medicine, University of California Irvine, 101 The City Drive S, Orange, CA 92868; zmoosvi{at}uci.edu

Alexander Abadir, MD

Department of Internal Medicine, University of California Irvine, Orange, CA

Jacqueline Duong, BS

University of California, Irvine

Douglas Nguyen, MD

Department of Gastroenterology and Hepatology, University of California Irvine, Orange, CA

Registration is Now Required for Free Access to CCJM Content

Register once and log in for full access to articles and content. Click “Register” in the upper right corner and follow the simple instructions to create a new account.

If you are using a mobile device, click on the settings icon to access the Register link.